| NCT ID | NCT06547372 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National University of Singapore |
| Condition | Atopic Dermatitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 110 participants |
| Start Date | 2024-05-10 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 110 participants in total. It began in 2024-05-10 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Diet is a key determinant of overall health, with growing evidence associating dietary patterns with allergic diseases. Among these, atopic dermatitis (AD) is of particular interest as it often represents the earliest manifestation of the atopic triad. Investigating dietary interventions in AD therefore provides a relevant model to better understand how diet may influence the onset and progression of allergic disease more broadly.
Eligibility Criteria
Inclusion Criteria: 1. Presence of current, mild-to-moderate atopic dermatitis/eczema at flexural areas 2. 21 to 65 years of age (inclusive) at screening 3. Must be English-literate and able to give informed consent in English 4. Be residing in Singapore and will not be travelling outside of Singapore during the study period 5. Reliable and willing to follow study procedures and be available for the duration of the study 6. Non-smokers (tobacco and e-cigarette) 7. Non-drinker (no regular or frequent consumption of alcohol) 8. Overtly healthy with no pre-existing medical conditions (e.g., diabetes, hypertension, cancer, blood disorders, degenerative/liver/autoimmune/immune/renal diseases, or psychiatric conditions) 9. No food allergies to test foods 10. No needle phobia 11. Be willing to follow the instruction provided by the investigators on the use of any moisturiser, cosmetics, and/or topical cream on the skin throughout the entire duration of the study. Exclusion Criteria: 1. Concurrent participation in other research studies 2. Pregnancy or lactating individuals 3. Known or ongoing psychiatric disorders within 3 years 4. Known severe nutritional deficiency 5. Vegetarian/vegans (as meat will be included in the diet) 6. Individuals who made a significant dietary change in the past 12 months 7. Having a pre-existing dietary restriction that would interfere with the adherence to a whole diet meal 8. Regular use of strong medication (western and/or traditional), therapies, and alternative medications 9. Regular nutritional supplements in the past 12 months Regular consumption of oral contraceptive pills and/or steroid hormones 10. Antibiotic use in the past 2 months 11. Any long-term hospitalisation or surgery during the 6 months before enrolment in study 12. Significant change in weight (+/- 5.0%) during the past month 13. History of bleeding diathesis or coagulopathy (or any bleeding disorders) 14. Having donated blood of more than 500 mL within 4 weeks of study enrolment
Contact & Investigator
Fook Tim CHEW, PhD
PRINCIPAL INVESTIGATOR
NUS Singapore
Frequently Asked Questions
Who can join the NCT06547372 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 65 Years, studying Atopic Dermatitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06547372 currently recruiting?
Yes, NCT06547372 is actively recruiting participants. Contact the research team at fstlmh@nus.edu.sg for enrollment information.
Where is the NCT06547372 trial being conducted?
This trial is being conducted at Singapore, Singapore.
Who is sponsoring the NCT06547372 clinical trial?
NCT06547372 is sponsored by National University of Singapore. The principal investigator is Fook Tim CHEW, PhD at NUS Singapore. The trial plans to enroll 110 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.